Trial Profile
Genetic markers of treatment response to tumour necrosis factor-alpha inhibitors in the treatment of psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 08 Dec 2015 New trial record